Herceptin 600mg Injection consists of Trastuzumab as an active constituent, which is indicated for its use in HER2 breast cancer. In HER2-positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumors by serving as a signal to the cancer. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancers are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Herceptin 660mg Injection is not recommended for patients aged under 18 and patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatments. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

• Advanced and metastatic breast cancer.
• Metastatic gastric cancer.

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Trastuzumab in Herceptin 660mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Herceptin 660mg Injection shall either be administered before or after surgery.

It will be given as an intravenous infusion for 90 minutes; if well tolerated, it shall be administered within 30 minutes for the next doses.

Serious:

Heart Problems

Allergic reactions

Kidney problems

Breathing difficulties

Common:

Fever

Visual disturbances

Nose bleeds or runny nose

Hair loss

Dizziness

Nail disorders

Weight loss

Loss of appetite

Bruising

Dry mouth

Liver inflammation

Muscle pain

Asthma/lung disorders

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Herceptin 660mg Injection and cause undesirable side effects.

• Store between 2˚C and 8˚C.
• Keep Herceptin 660mg Injection out of sight and reach of children.

It is suggested to inform your doctor if you have a history of allergic reactions to Herceptin 660mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems, inform your doctor beforehand before the treatment commences. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Herceptin 660mg Injection as it may impact the functioning of the heart.